LUPINNSELUPIN LIMITED· Pharmaceuticals & BiotechnologyHighNegative
Announced Tue, 18 Aug, 2026 · 22:04 IST

Lupin senior management personnel Dr. Sofia Mumtaz passes away

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹2232.00
prior close
₹2230.00
announcement price
After-mkt
timing
Nifty Midcap 150market-0.3%-0.1% vs market
Pharmaceuticals peers, median of 175sector-0.6%+0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Midcap 150 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.4
15m
-0.4
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3-0.3-0.1-0.6+0.3
Next day
-1.4+0.1-1.5-0.1-1.2
2d
-1.4+0.2-1.5-0.1-1.2
3d
-2.1+0.3-2.4-0.3-1.8
4d
-2.7+0.7-3.4-0.7-2.0
5d
-1.5+0.7-2.3+0.0-1.6
1w
-2.5+0.6-3.1+0.5-3.0
15d
-5.9-1.6-4.3+1.1-7.0
1m
-4.8-2.3-2.4+1.9-6.7
2m
-13.1-8.0-5.1-4.4-8.8
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lupin Limited informed the stock exchanges about the sad demise of Dr. Sofia Mumtaz, President of Legal and Compliance for Canada, ANZ and NEA Business, on August 17, 2026 in the USA. She was a Senior Management Personnel of the company. The disclosure was filed under SEBI Listing Regulations, and the company may announce a successor in due course.

Likely market impact

Loss of a senior legal and compliance leader. Likely minor near-term impact; watch for succession announcement.